“Live high‐train low” induced changes in hemoglobin mass and the erythropoietin‐erythroferrone‐hepcidin axis in female endurance athletes
Physiological Reports · 2025
DOI: 10.14814/phy2.70707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Titta Kuorelahti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sports Technology Unit Vuokatti, Faculty of Sport and Health Sciences, University of Jyväskylä, Vuokatti, Finland. Hauptthemen laut MEDLINE: Erythropoietin, Hepcidins, Hemoglobins, Physical Endurance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Opetus-ja Kulttuuriministeriö (Ministry of Education and Culture, Finland), Seppo Säynäjäkangas Science Foundation, SKR | Kainuun Rahasto (Kainuu Regional Fund).
Abstract (Originalsprache)
The effects of a 21‐day live high‐train low (LHTL) on hemoglobin mass (Hb mass ) and iron demand including the erythropoietin (EPO)‐erythroferrone (ERFE)‐hepcidin axis and routine iron markers were investigated. Fifteen female endurance athletes completed either 21‐day LHTL in normobaric hypoxia (2500 m, ~18 h·day −1 ) (INT, n = 8) or lived and trained in normoxia (CON, n = 7). Hb mass and resting blood were collected before and after the intervention. An additional blood sample was collected on Day 6 for INT. 21‐day LHTL increased Hb mass 3.8% in INT ( p < 0.001). EPO increased 35.6% from Day 0 to Day 6 in INT ( p = 0.037) and then decreased 42.4% from Day 6 to Day 21 ( p = 0.019). In INT, no changes were detected in ERFE or hepcidin, and from the routine iron markers only serum transferrin receptor increased from Day 0 to Day 21 (13.9%, p = 0.013). In CON, no changes were detected in Hb mass or iron markers. In INT, Hb mass and ferritin were positively associated (Day 0 to Day 6, p = 0.005). Thus, hepcidin and ERFE may not provide additional information regarding iron demand following 6‐ or 21‐day LHTL compared to routine iron markers. The relationship between Hb mass and ferritin indicates that adequate ferritin levels are needed during hypoxia to support hematological adaptations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sports Technology Unit Vuokatti, Faculty of Sport and Health Sciences, University of Jyväskylä, Vuokatti, Finland.
- Finnish Institute of High Performance Sport KIHU, Jyväskylä, Finland.
- East Metropolitan Health Service, Royal Perth, Perth, Western Australia, Australia.
- School of Medical and Health Science, Edith Cowan University, Perth, Western Australia, Australia.
ORCID-Profile: Titta Kuorelahti, Johanna K Ihalainen
Förderung
- Opetus-ja Kulttuuriministeriö (Ministry of Education and Culture, Finland)
- Seppo Säynäjäkangas Science Foundation
- SKR | Kainuun Rahasto (Kainuu Regional Fund)
- Opetus- ja Kulttuuriministeriö
- Kainuun Rahasto
Zitieren
APA
Kuorelahti, T., Ihalainen, J. K., Linnamo, V., Badenhorst, C., Kettunen, O., & Mikkonen, R. (2025). “Live high‐train low” induced changes in hemoglobin mass and the erythropoietin‐erythroferrone‐hepcidin axis in female endurance athletes. Physiological Reports. https://doi.org/10.14814/phy2.70707
Vancouver
Kuorelahti T, Ihalainen JK, Linnamo V, Badenhorst C, Kettunen O, Mikkonen R. “Live high‐train low” induced changes in hemoglobin mass and the erythropoietin‐erythroferrone‐hepcidin axis in female endurance athletes. Physiological Reports. 2025. doi:10.14814/phy2.70707
BibTeX
@article{Kuorelahti2025,
author = {Kuorelahti, Titta and Ihalainen, Johanna K and Linnamo, Vesa and Badenhorst, Claire and Kettunen, Oona and Mikkonen, Ritva},
title = {“Live high‐train low” induced changes in hemoglobin mass and the erythropoietin‐erythroferrone‐hepcidin axis in female endurance athletes},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70707}
}
EUVIMED